Karl Deisseroth, a US psychiatrist and neurologist, alongside his German colleagues Peter Hegemann and Georg Nagel, have been awarded the Nobel Prize in Physiology or Medicine. Their pioneering work in optogenetics has provided groundbreaking insights into the brain's complex mechanisms.
The Nobel Committee praised the trio for creating a new era in neuroscience. Their research has enabled scientists to manipulate neural circuits linked to specific memories, emotions, and behaviors, which are crucial for understanding neurological and psychiatric disorders. The committee emphasized that optogenetics has fundamentally transformed our comprehension of the brain.
Optogenetics involves using a special protein from algae to control cell electrical activity with light. In the early 2000s, Hegemann and Nagel identified channelrhodopsin, an algal protein with unique properties. Deisseroth then applied this discovery to activate nerve cells in mice brains. This technique has since allowed researchers to explore nerve cells and pathways in animals, providing vital insights into brain functions.
The Nobel Assembly highlighted the potential of optogenetics in clinical medicine. Researchers are now able to switch individual neural circuits on or off, bringing memories to life, creating feelings, and driving behaviors. This capability is offering valuable insights into the nervous system's interaction with other body cells, such as those in the heart and gut.
In addition to its research applications, optogenetics is being explored as a potential medical treatment. Clinical trials are underway to restore vision in patients blinded by retinitis pigmentosa, a condition that damages the eye's rods and cones. By inserting a special protein into the affected area of the eye, patients have regained some vision using special glasses that emit light, activating the therapeutic algae proteins.
Per Svenningsson, chair of the Nobel Committee for Physiology or Medicine, expressed enthusiasm about the potential of optogenetics, stating it offers opportunities for brain mapping that were once unimaginable. The winners expressed their delight at receiving the award, describing it as an honor to share the accolade with friends. They will share the £900,000 (12 million Swedish kronor) prize money.
The Nobel Committee concluded that the daily discoveries made possible by optogenetics are helping to unravel one of humanity's greatest mysteries: the workings of the brain. As researchers continue to explore this field, the implications of their findings could lead to significant advancements in understanding and treating neurological and psychiatric disorders.
